StockData
CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc. (CNSP) stock

CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$4.15+0.67 (+19.25%)

Close on Nov 17, 2026Market cap $6.07MP/E –Yield –

CNS Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CNS Pharmaceuticals's price to book ratio was 0.3× on Nov 11, 2026, against 0.4× a year earlier. Over the last 3 years it ranged from 0.2× to 481.3×, with a median of 2.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.0
2025Dec 31, 20250.3×−179.9
2023Apr 28, 2023180.2×−73.8
2022Dec 30, 2022253.9×–

More CNS Pharmaceuticals figures

See a number that looks wrong?